Remarkably similar changes were observed in the 4T1 model, where systemic NOS2 depletion and indomethacin treatment led to increased CD8+ T cell infiltration, N1 neutrophils, and active B cells, which translated to increased cures in 4T1 tumor-bearing mice (24). The gene discussed is CD8A; the disease is neoplasm.